🇧🇷 Dihydroergocriptine in Brazil

Dihydroergocriptine (dihydroergocryptine) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Dihydroergocriptine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in Brazil

Frequently asked questions

Is Dihydroergocriptine approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Dihydroergocriptine in Brazil?

Marketing authorisation holder not available in our data.